Integrated bioinformatics analysis of miRNA expression in osteosarcoma

References

• Argast GM, Campbell JS, Brooling JT, Fausto N. 2004. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J Biol Chem. 279:34530–34536.
   PubMed Web of Science ®Google Scholar
• Ayaz L, Görür A, Yaroğlu HY, Ozcan C, Tamer L. 2013. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 139:1499–1506.
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 101:2999–3004.
   PubMed Web of Science ®Google Scholar
• Laflamme C, Filion C, Bridge JA, Ladanyi M, Goldring MB, Labelle Y. 2003. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas. Cancer Res. 63:449–454.
   PubMed Web of Science ®Google Scholar
• Li D, Jian W, Wei C, Song H, Gu Y, Luo Y, Fang L. 2014. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Int J Clin Exp Pathol. 7:7672–7680.
   PubMed Web of Science ®Google Scholar
• Dennis G Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4:P3.
   PubMed Web of Science ®Google Scholar
• Doench JG, Sharp PA. 2004. Specificity of microRNA target selection in translational repression. Genes Dev. 18:504–511.
   PubMed Web of Science ®Google Scholar
• Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, et al. 2011. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther. 10:1337–1345.
   PubMed Web of Science ®Google Scholar
• Essaghir A, Toffalini F, Knoops L, Kallin A, van Helden J, Demoulin JB. 2010. Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic Acids Res. 38:e120.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36:D154–D158.
   PubMed Web of Science ®Google Scholar
• Hu H, Zhang Y, Cai XH, Huang J-F, Cai L. 2012. Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. Oncol Lett. 4:1037–1042.
   PubMed Web of Science ®Google Scholar
• Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D'Ascenzo S, et al. 2005. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res. 65:9369–9376.
   PubMed Web of Science ®Google Scholar
• Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, et al. 2012. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 72:1865–1877.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. 2011. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39:D152–D157.
   PubMed Web of Science ®Google Scholar
• Glunde K, Jie C, Bhujwalla ZM. 2004. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res. 64:4270–4276.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20.
   PubMed Web of Science ®Google Scholar
• Liu JF, Xie HJ, Cheng TM. 2013. Lack of any association between insertion/deletion (I/D) polymorphisms in the angiotensin-converting enzyme gene and digestive system cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 14:7271–7275.
   PubMedGoogle Scholar
• Maire G, Martin JW, Yoshimoto M, Chilton-MacNeill S, Zielenska M, Squire JA. 2011. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma. Cancer Genet. 204:138–146.
   PubMed Web of Science ®Google Scholar
• Mo ML, Okamoto J, Chen Z, Hirata T, Mikami I, Bosco-Clément G, et al. 2013. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma. PLoS One. 8:e71816.
   PubMed Web of Science ®Google Scholar
• Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, et al. 2012. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 7:e48086.
   PubMed Web of Science ®Google Scholar
• Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. 2009. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23:2839–2849.
   PubMed Web of Science ®Google Scholar
• Ottaviani G, Jaffe N. 2009. The epidemiology of osteosarcoma. Cancer Treat Res. 152:3–13.
   PubMedGoogle Scholar
• Kumar R, Balasenthil S, Manavathi B, Rayala SK, Pakala SB. 2010. Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor. Cancer Res. 70:6649–6658.
   PubMed Web of Science ®Google Scholar
• Hart S, Fischer OM, Ullrich A. 2004. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 64:1943–1950.
   PubMed Web of Science ®Google Scholar
• Shi XB, Tepper CG, deVere White RW, 2008. Cancerous miRNAs and their regulation. Cell Cycle. 7:1529–1538.
   PubMed Web of Science ®Google Scholar
• Skaftnesmo KO, Prestegarden L, Micklem DR, Lorens JB. 2007. MicroRNAs in tumorigenesis. Curr Pharm Biotechnol. 8:320–325.
   PubMed Web of Science ®Google Scholar
• Tan ML, Choong PF, Dass CR. 2009. Osteosarcoma: conventional treatment vs. gene therapy. Cancer Biol Ther. 8:106–117.
   PubMed Web of Science ®Google Scholar
• Thayanithy V, Sarver AL, Kartha RV, Li L, Angstadt AY, Breen M, et al. 2012. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone. 50:171–181.
   PubMed Web of Science ®Google Scholar
• Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 132:875–886.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li M, Li L, Yang X, Lan G, Zhang Y. 2013. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One. 8:e83571.
   PubMed Web of Science ®Google Scholar